Review article · 2020
Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders
European Journal of Medicinal Chemistry, 192, 112155 · Published 18 February 2020 · DOI 10.1016/j.ejmech.2020.112155
In brief
“Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders” is a 2020 review article by Pengfei Xu and 9 co-authors, published in European Journal of Medicinal Chemistry. OpenAlex counts 86 citations as of 21 November 2026, which puts it in the top 2% of works published in 2020 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 86
- Most cited in
- 2024 (18)
- Field-weighted impact
- 1.01
- References
- 151
- Authors
- 10
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Xu, P., Shen, P., Yu, B., Xu, X. J., Ge, R., Cheng, X., Chen, Q., Bian, J., Li, Z., & Wang, J. (2020). Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders. European Journal of Medicinal Chemistry, 192, 112155. https://doi.org/10.1016/j.ejmech.2020.112155
MLA 9
Xu, Pengfei, et al. “Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders.” European Journal of Medicinal Chemistry, vol. 192, 2020, p. 112155. https://doi.org/10.1016/j.ejmech.2020.112155.
Chicago
Xu, Pengfei, Pei Shen, Bin Yu, Xi Jin Xu, Raoling Ge, Xinying Cheng, Qiuyu Chen, Jinlei Bian, Zhiyu Li, and JuBo Wang. 2020. “Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders.” European Journal of Medicinal Chemistry 192: 112155. https://doi.org/10.1016/j.ejmech.2020.112155.
Harvard
Xu, P. et al. (2020) ‘Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders’, European Journal of Medicinal Chemistry, 192, p. 112155. doi:10.1016/j.ejmech.2020.112155.
IEEE
P. Xu et al., “Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders,” European Journal of Medicinal Chemistry, vol. 192, p. 112155, 2020, doi: 10.1016/j.ejmech.2020.112155.
BibTeX
@article{xu2020janus,
title = {{Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders}},
author = {Xu, Pengfei and Shen, Pei and Yu, Bin and Xu, Xi Jin and Ge, Raoling and Cheng, Xinying and Chen, Qiuyu and Bian, Jinlei and Li, Zhiyu and Wang, JuBo},
journal = {European Journal of Medicinal Chemistry},
year = {2020},
volume = {192},
pages = {112155},
doi = {10.1016/j.ejmech.2020.112155},
url = {https://doi.org/10.1016/j.ejmech.2020.112155}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2020 | 9 | |
| 2021 | 7 | |
| 2022 | 12 | |
| 2023 | 16 | |
| 2024 | 18 | |
| 2025 | 13 | |
| 2026 | 11 |
Its field-weighted citation impact is 1.01: it has been cited 1.01 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Janus kinase
- JAK inhibitors
- autoimmune disease
- myeloproliferative neoplasms
- JAK/STAT signaling
- cytokine signaling
- STAT phosphorylation
- small-molecule kinase inhibitors
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Xu, P., Shen, P., Yu, B., Xu, X. J., Ge, R., Cheng, X., Chen, Q., Bian, J., Li, Z., & Wang, J. (2020). Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders. European Journal of Medicinal Chemistry, 192, 112155. https://doi.org/10.1016/j.ejmech.2020.112155
How many times has this paper been cited?
86 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Pengfei Xu, Pei Shen, Bin Yu, Xi Jin Xu, Raoling Ge, Xinying Cheng, Qiuyu Chen, Jinlei Bian, Zhiyu Li, JuBo Wang.
What is the DOI of this paper?
10.1016/j.ejmech.2020.112155, permanently at https://doi.org/10.1016/j.ejmech.2020.112155. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.